Detalhe da pesquisa
1.
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(7): 798-810, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290468
2.
Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma.
BMC Cancer
; 23(1): 7, 2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597072
3.
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
BMC Cancer
; 21(1): 534, 2021 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33975558
4.
Association between PT, PT-INR, and in-hospital mortality in critically ill patients with tumors: A retrospective cohort study.
Front Public Health
; 11: 1036463, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026132
5.
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.
Eur J Cancer
; 194: 113336, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801967
6.
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial.
J Clin Oncol
; 40(11): 1163-1173, 2022 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34990291
7.
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.
Radiother Oncol
; 160: 9-17, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33839205
8.
Efficacy of Transnasal Endoscopic Fine-Needle Aspiration Biopsy in Diagnosing Submucosal Nasopharyngeal Carcinoma.
Laryngoscope
; 131(8): 1798-1804, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33616259
9.
Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study.
Ann Transl Med
; 9(7): 532, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33987230
10.
Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma.
Ther Adv Med Oncol
; 12: 1758835920928214, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32536983
11.
The impact of Adult Comorbidity Evaluation-27 on the clinical outcome of elderly nasopharyngeal carcinoma patients treated with chemoradiotherapy or radiotherapy: a matched cohort analysis.
J Cancer
; 10(23): 5614-5621, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31737097
12.
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy response.
Radiother Oncol
; 137: 83-94, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31078941